CliniGA CRO

CliniGA CRO Blog

Maintaining long-term contact in implant investigations

Plan participant contact, site transitions and open responsibilities across extended follow-up.

Representative research photograph: Maintaining long-term contact in implant investigations
Photo: U.S. Navy photo by Petty Officer 2nd Class Kaleb Birch · License: Public domain · Cropped and resized.
Published
Updated

Fewer active visits do not automatically preserve the ability to contact participants in an implant investigation. Site closure, staff turnover or relocation can lead to missing long-term findings. Translate continuity into assigned tasks early in planning.

Define the assessment

Define the follow-up purpose, contact frequency and information needed. Use contact routes permitted by participants; collecting more personal information does not necessarily improve follow-up. Explain the differences between clinical care, research assessments and emergency contact arrangements.

Worked example

For example, a participant moves to another city as the site team changes. A recent call entry appears reassuring, but responsibility was never transferred. The coordinator verifies follow-up status, permitted contact routes and local care connections. Missed assessments remain visibly missing rather than being completed as though they occurred.

Practical checks

  • Assign responsibility for updating contact details and controlling authorised access.
  • Reconcile individual open follow-ups during site or personnel transitions.
  • Distinguish inability to contact from death, withdrawal and other follow-up states.

Decision and limitations

The plan should explain what the team may seek years later and under which permissions. Respect participant preferences and local privacy requirements. Consider possible differences among people lost to follow-up when interpreting findings; call counts alone do not establish follow-up quality.

Frequently asked questions

Do more calls mean better follow-up?
No. Valid assessments, participant preferences and explanations of missing follow-up all matter.
Does site closure end follow-up?
Not automatically. Assess remaining responsibilities and appropriate transfer arrangements against the investigation plan.

Sources

  1. MDCG 2024-3 — Clinical investigation plan
  2. MDCG 2020-7 — PMCF plan